Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)

Market Cap	10.09B
Revenue (ttm)	2.23B
Net Income (ttm)	594.62M
Shares Out	530.17M
EPS (ttm)	1.12
PE Ratio	16.97
Forward PE	n/a
Dividend	0.48 (2.52%)
Ex-Dividend Date	Jul 4, 2024

Volume	533,000
Open	19.47
Previous Close	19.06
Day's Range	19.00 - 19.47
52-Week Range	16.27 - 26.48
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Tibet Cheezheng Tibetan Medicine

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. It provides products in the areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,091
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2023, Tibet Cheezheng Tibetan Medicine's revenue was 2.05 billion, an increase of 0.02% compared to the previous year's 2.04 billion. Earnings were 581.20 million, an increase of 22.99%.